Clinical Trial Update: Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on managing severe chemotherapy-induced neutropenia in advanced breast cancer, completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Febrile Neutropenia

Snippet

Sponsor: Enzychem Lifesciences Corporation | Conditions: Febrile Neutropenia | Phase 1, Phase 2 | Status: COMPLETED